Intestinal microbiota promotes psoriasis-like skin inflammation by enhancing Th17 response

PLoS ONE

Volumn 11, Issue 7, 2016, Pages

  Zákostelská, Zuzana ^a   Málková, Jana ^a   Klimešová, Klára ^a,b   Rossmann, Pavel ^a   Hornová, Michaela ^a   Novosádová, Iva ^a   Stehlíková, Zuzana ^a   Kostovčík, Martin ^a   Hudcovic, Tomáš ^a   Štepánková, Renata ^a   Jůzlová, Kateřina ^c   Hercogová, Jana ^c   Tlaskalová Hogenová, Helena ^a   Kverka, Miloslav ^a,d  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^c UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMIQUIMOD; INTERLEUKIN 17; AMINOQUINOLINE DERIVATIVE; ANTIINFECTIVE AGENT; LYMPHOCYTE ANTIGEN RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RORC PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CLOSTRIDIALES; CONTROLLED STUDY; CORIOBACTERIALES; CYTOKINE PRODUCTION; ERYSIPELOTRICHIALE; FEMALE; FIRMICUTES; GAMMA DELTA T CELL RECEPTOR+ T CELL; IMMUNOREACTIVITY; INTESTINE FLORA; LACTOBACILLALES; LYMPHOCYTE ACTIVATION; MICROBIAL DIVERSITY; MOUSE; MURINE MODEL; NONHUMAN; PHYLUM; PSORIASIS; SPECIES COMPOSITION; T LYMPHOCYTE; TH17 CELL; ACTINOBACTERIA; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; GERMFREE ANIMAL; HUMAN; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SKIN; SPECIES DIFFERENCE;

ACTINOBACTERIA; AMINOQUINOLINES; ANIMALS; ANTI-BACTERIAL AGENTS; CLOSTRIDIALES; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL MICROBIOME; GENE EXPRESSION; GERM-FREE LIFE; HUMANS; INTERLEUKIN-17; LACTOBACILLALES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PSORIASIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SKIN; SPECIES SPECIFICITY; TH17 CELLS;

EID: 84979608000     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.015953     Document Type: Article

References (42)

1. Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013; 133(2):377-85. Epub 2012/09/28. jid2012339 [pii] doi: 10.1038/jid.2012.339 PMID: 23014338.
2. Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009; 129(6):1339-50. Epub 2009/03/27. jid200959 [pii] doi: 10.1038/jid.2009.59 PMID: 19322214.
3. Bhatia BK, Millsop JW, Debbaneh M, Koo J, Linos E, Liao W. Diet and psoriasis, part II: celiac disease and role of a gluten-free diet. J Am Acad Dermatol. 2014; 71(2):350-8. Epub 2014/05/02. S0190-9622(14)01244-4 [pii] doi: 10.1016/j.jaad.2014.03.017 PMID: 24780176; PubMed Central PMCID: PMC4104239.
4. Debbaneh M, Millsop JW, Bhatia BK, Koo J, Liao W. Diet and psoriasis, part I: Impact of weight loss interventions. J Am Acad Dermatol. 2014; 71(1):133-40. Epub 2014/04/09. S0190-9622(14)01126-8 [pii] doi: 10.1016/j.jaad.2014.02.012 PMID: 24709272; PubMed Central PMCID: PMC4065614.
5. Di Meglio P, Duarte JH, Ahlfors H, Owens ND, Li Y, Villanova F, et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity. 2014; 40(6):989-1001. Epub 2014/06/10. S1074-7613(14)00183-6 [pii] doi: 10.1016/j.immuni.2014.04.019 PMID: 24909886; PubMed Central PMCID: PMC4067745.
6. Fry L, Baker BS, Powles AV, Fahlen A, Engstrand L. Is chronic plaque psoriasis triggered by microbiota in the skin? Br J Dermatol. 2013; 169(1):47-52. Epub 2013/03/26. doi: 10.1111/bjd.12322 PMID: 23521130.
7. Noah PW. The role of microorganisms in psoriasis. Semin Dermatol. 1990; 9(4):269-76. Epub 1990/12/01. PMID: 2285571.
8. McFadden JP, Baker BS, Powles AV, Fry L. Psoriasis and streptococci: the natural selection of psoriasis revisited. Br J Dermatol. 2009; 160(5):929-37. Epub 2009/03/25. BJD9102 [pii] doi: 10.1111/j.1365-2133.2009.09102.x PMID: 19309365.
9. Naldi L, Peli L, Parazzini F, Carrel CF. Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol. 2001; 44(3):433-8. Epub 2001/02/24. S0190-9622(01)37292-4 [pii] doi: 10.1067/mjd.2001.110876 PMID: 11209111.
10. Alekseyenko AV, Perez-Perez GI, De Souza A, Strober B, Gao Z, Bihan M, et al. Community differentiation of the cutaneous microbiota in psoriasis. Microbiome. 2013; 1(1):31. Epub 2014/01/24. 2049-2618-1-31 [pii] doi: 10.1186/2049-2618-1-31 PMID: 24451201; PubMed Central PMCID: PMC4177411.
11. Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One. 2008; 3(7):e2719. Epub 2008/07/24. doi: 10.1371/journal.pone.0002719 PMID: 18648509; PubMed Central PMCID: PMC2447873.
12. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009; 139(3):485-98. doi: 10.1016/j.cell.2009.09.033 PMID: 19836068; PubMed Central PMCID: PMCPMC2796826.
13. Stepankova R, Powrie F, Kofronova O, Kozakova H, Hudcovic T, Hrncir T, et al. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm Bowel Dis. 2007; 13(10):1202-11. Epub 2007/07/04. doi: 10.1002/ibd.20221 PMID: 17607724.
14. Hansen CH, Nielsen DS, Kverka M, Zakostelska Z, Klimesova K, Hudcovic T, et al. Patterns of early gut colonization shape future immune responses of the host. PLoS One. 2012; 7(3):e34043. doi: 10.1371/journal.pone.0034043 PMID: 22479515; PubMed Central PMCID: PMCPMC3313961.
15. Zanvit P, Konkel JE, Jiao X, Kasagi S, Zhang D, Wu R, et al. Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis. Nat Commun. 2015; 6:8424. Epub 2015/09/30. ncomms9424 [pii] doi: 10.1038/ncomms9424 PMID: 26416167; PubMed Central PMCID: PMC4598725.
16. Klimesova K, Kverka M, Zakostelska Z, Hudcovic T, Hrncir T, Stepankova R, et al. Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice. Inflamm Bowel Dis. 2013; 19(6):1266-77. doi: 10.1097/MIB.0b013e318281330a PMID: 23567778; PubMed Central PMCID: PMCPMC3744230.
17. Hrncir T, Stepankova R, Kozakova H, Hudcovic T, Tlaskalova-Hogenova H. Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice. BMC Immunol. 2008; 9:65. Epub 2008/11/08. 1471-2172-9-65 [pii] doi: 10.1186/1471-2172-9-65 PMID: 18990206; PubMed Central PMCID: PMC2588440.
18. van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 2009; 182(9):5836-45. Epub 2009/04/22. 182/9/5836 [pii] doi: 10.4049/jimmunol.0802999 PMID: 19380832.
19. Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol. 2010; 3(2):148-58. Epub 2009/11/27. mi2009132 [pii] doi: 10.1038/mi.2009.132 PMID: 19940845; PubMed Central PMCID: PMC2824244.
20. Reikvam DH, Erofeev A, Sandvik A, Grcic V, Jahnsen FL, Gaustad P, et al. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One. 2011; 6(3):e17996. Epub 2011/03/30. doi: 10.1371/journal.pone.0017996 PMID: 21445311; PubMed Central PMCID: PMC3061881.
21. Zakostelska Z, Kverka M, Klimesova K, Rossmann P, Mrazek J, Kopecny J, et al. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS One. 2011; 6(11):e27961. doi: 10.1371/journal.pone.0027961 PMID: 22132181; PubMed Central PMCID: PMCPMC3222668.
22. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010; 7(5):335-6. Epub 2010/04/13. nmeth.f.303 [pii] doi: 10.1038/nmeth.f.303 PMID: 20383131; PubMed Central PMCID: PMC3156573.
23. Bacchetti De Gregoris T, Aldred N, Clare AS, Burgess JG. Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. J Microbiol Methods. 2011; 86(3):351-6. doi: 10.1016/j.mimet.2011.06.010 PMID: 21704084.
24. Pantelyushin S, Haak S, Ingold B, Kulig P, Heppner FL, Navarini AA, et al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J Clin Invest. 2012; 122(6):2252-6. Epub 2012/05/02. 61862 [pii] doi: 10.1172/JCI61862 PMID: 22546855; PubMed Central PMCID: PMC3366412.
25. Yoshiki R, Kabashima K, Honda T, Nakamizo S, Sawada Y, Sugita K, et al. IL-23 from Langerhans cells is required for the development of imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing gammadelta T cells. J Invest Dermatol. 2014; 134(7):1912-21. Epub 2014/02/27. jid201498 [pii] doi: 10.1038/jid.2014.98 PMID: 24569709.
26. Tlaskalova-Hogenova H, Stepankova R, Kozakova H, Hudcovic T, Vannucci L, Tuckova L, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol. 2011; 8(2):110-20. Epub 2011/02/01. cmi201067 [pii] doi: 10.1038/cmi.2010.67 PMID: 21278760.
27. Gomez de Aguero M, Ganal-Vonarburg SC, Fuhrer T, Rupp S, Uchimura Y, Li H, et al. The maternal microbiota drives early postnatal innate immune development. Science. 2016; 351(6279):1296-302. doi: 10.1126/science.aad2571 PMID: 26989247.
28. Flutter B, Nestle FO. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur J Immunol. 2013; 43(12):3138-46. Epub 2013/11/21. doi: 10.1002/eji.201343801 PMID: 24254490.
29. Arck P, Handjiski B, Hagen E, Pincus M, Bruenahl C, Bienenstock J, et al. Is there a 'gut-brain-skin axis'? Exp Dermatol. 2010; 19(5):401-5. Epub 2010/02/02. EXD1060 [pii] doi: 10.1111/j.1600-0625.2009.01060.x PMID: 20113345.
30. Bowe W, Patel NB, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine. Benef Microbes. 2014; 5(2):185-99. Epub 2013/07/28. 0U3X16807123W358 [pii] doi: 10.3920/BM2012.0060 PMID: 23886975.
31. Majamaa H, Isolauri E. Evaluation of the gut mucosal barrier: evidence for increased antigen transfer in children with atopic eczema. J Allergy Clin Immunol. 1996; 97(4):985-90. Epub 1996/04/01. S0091674996000899 [pii]. PMID: 8655895.
32. Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008; 6(7):759-64. Epub 2008/05/06. S1542-3565(08)00155-9 [pii] doi: 10.1016/j.cgh.2008.02.054 PMID: 18456568.
33. Huang BL, Chandra S, Shih DQ. Skin manifestations of inflammatory bowel disease. Front Physiol. 2012; 3:13. Epub 2012/02/22. doi: 10.3389/fphys.2012.00013 PMID: 22347192; PubMed Central PMCID: PMC3273725.
34. Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015; 12(10):561-71. Epub 2015/08/12. nrgastro.2015.131 [pii] doi: 10.1038/nrgastro.2015.131 PMID: 26260366.
35. Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015; 67(1):128-39. Epub 2014/10/17. doi: 10.1002/art.38892 PMID: 25319745; PubMed Central PMCID: PMC4280348.
36. Weinstock LB, Steinhoff M. Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin. J Am Acad Dermatol. 2013; 68(5):875-6. Epub 2013/04/23. S0190-9622(12)02330-4 [pii] doi: 10.1016/j.jaad.2012.11.038 PMID: 23602178.
37. Bjorksten B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy. 1999; 29(3):342-6. Epub 1999/04/15. PMID: 10202341.
38. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997; 99(2):179-85. Epub 1997/02/01. S0091674997000304 [pii]. PMID: 9042042.
39. Viljanen M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy. 2005; 60(4):494-500. Epub 2005/02/25. ALL514 [pii] doi: 10.1111/j.1398-9995.2004.00514.x PMID: 1572758.
40. Chen L, Zou Y, Peng J, Lu F, Yin Y, Li F, et al. Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis. J Immunol Res. 2015; 2015:909514. Epub 2015/05/15. doi: 10.1155/2015/909514 PMID: 25973440; PubMed Central PMCID: PMC4417982.
41. Cardone M, Dzutsev AK, Li H, Riteau N, Gerosa F, Shenderov K, et al. Interleukin-1 and interferon-gamma orchestrate beta-glucan-activated human dendritic cell programming via IkappaB-zeta modulation. PLoS One. 2014; 9(12):e114516. Epub 2014/12/05. doi: 10.1371/journal.pone.0114516 PONE-D-14-36425 [pii]. PMID: 25474109; PubMed Central PMCID: PMC4256441.
42. Johansen C, Mose M, Ommen P, Bertelsen T, Vinter H, Hailfinger S, et al. IkappaBzeta is a key driver in the development of psoriasis. Proc Natl Acad Sci U S A. 2015; 112(43):E5825-33. Epub 2015/10/16. 1509971112 [pii] doi: 10.1073/pnas.1509971112 PMID: 26460049; PubMed Central PMCID: PMC4629387.